Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Operations: 2015-2024

Historic Cash from Operations for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$135.3 million.

  • Anaptysbio's Cash from Operations fell 171.12% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$145.0 million, marking a year-over-year decrease of 40.73%. This contributed to the annual value of -$135.3 million for FY2024, which is 12.03% down from last year.
  • Latest data reveals that Anaptysbio reported Cash from Operations of -$135.3 million as of FY2024, which was down 12.03% from -$120.8 million recorded in FY2023.
  • Anaptysbio's 5-year Cash from Operations high stood at -$14.2 million for FY2020, and its period low was -$135.3 million during FY2024.
  • In the last 3 years, Anaptysbio's Cash from Operations had a median value of -$120.8 million in 2023 and averaged -$109.9 million.
  • As far as peak fluctuations go, Anaptysbio's Cash from Operations spiked by 79.64% in 2020, and later crashed by 224.36% in 2021.
  • Over the past 5 years, Anaptysbio's Cash from Operations (Yearly) stood at -$14.2 million in 2020, then crashed by 224.36% to -$45.9 million in 2021, then slumped by 60.26% to -$73.6 million in 2022, then tumbled by 64.15% to -$120.8 million in 2023, then declined by 12.03% to -$135.3 million in 2024.